Ftse Mib
37.977,59
0,18%
DAX
22.513,42
-0,43%
S&P 500
6.114,63
-0,01%
NASDAQ
20.026,77
0,41%
Bitcoin
97.056,63
-0,55%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Xenon Pharmaceuticals Inc (XENE) Xenon Pharmaceuticals Inc (XENE) Notizie

XENE

Xenon Pharmaceuticals (XENE)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:XENE
DataOraFonteTitoloSimboloCompagnia
28/01/202502:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
28/01/202502:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XENEXenon Pharmaceuticals Inc
17/01/202515:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XENEXenon Pharmaceuticals Inc
13/01/202514:30GlobeNewswire Inc.Xenon Outlines Key Corporate Milestone Opportunities for 2025NASDAQ:XENEXenon Pharmaceuticals Inc
07/01/202514:30GlobeNewswire Inc.Xenon to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
06/12/202422:01GlobeNewswire Inc.Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024NASDAQ:XENEXenon Pharmaceuticals Inc
25/11/202414:30GlobeNewswire Inc.Xenon to Showcase New Long-Term Azetukalner Data at AES 2024NASDAQ:XENEXenon Pharmaceuticals Inc
13/11/202422:01GlobeNewswire Inc.Xenon to Present at Upcoming Investor ConferencesNASDAQ:XENEXenon Pharmaceuticals Inc
12/11/202422:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XENEXenon Pharmaceuticals Inc
12/11/202422:01GlobeNewswire Inc.Xenon Reports Q3 2024 Financial Results and Business UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
05/11/202422:01GlobeNewswire Inc.Xenon to Report Q3 2024 Financial Results on November 12, 2024NASDAQ:XENEXenon Pharmaceuticals Inc
02/10/202422:28GlobeNewswire Inc.Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
09/09/202414:30GlobeNewswire Inc.Xenon Showcases Azetukalner Data at 15th European Epilepsy CongressNASDAQ:XENEXenon Pharmaceuticals Inc
12/08/202414:30GlobeNewswire Inc.Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating OfficerNASDAQ:XENEXenon Pharmaceuticals Inc
09/08/202422:57Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:XENEXenon Pharmaceuticals Inc
08/08/202422:01GlobeNewswire Inc.Xenon Reports Q2 2024 Financial Results and Business UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
01/08/202422:01GlobeNewswire Inc.Xenon to Report Q2 2024 Financial Results on August 8, 2024NASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202422:22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XENEXenon Pharmaceuticals Inc
05/06/202422:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
28/05/202414:30GlobeNewswire Inc.Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual MeetingNASDAQ:XENEXenon Pharmaceuticals Inc
09/05/202422:01GlobeNewswire Inc.Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
08/05/202422:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024NASDAQ:XENEXenon Pharmaceuticals Inc
07/05/202422:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
02/05/202422:01GlobeNewswire Inc.Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
16/04/202414:30GlobeNewswire Inc.Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual MeetingNASDAQ:XENEXenon Pharmaceuticals Inc
04/04/202422:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:XENEXenon Pharmaceuticals Inc
12/03/202421:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS DaysNASDAQ:XENEXenon Pharmaceuticals Inc
05/03/202422:01GlobeNewswire Inc.Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024NASDAQ:XENEXenon Pharmaceuticals Inc
29/02/202422:01GlobeNewswire Inc.Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
22/02/202422:01GlobeNewswire Inc.Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate UpdateNASDAQ:XENEXenon Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:XENE

La tua Cronologia

TG
A2RYD9
Daimler International Fi...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci